Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in bone marrow transplantation.

R J Levinsky1

  • 1Institute of Child Health, London, United Kingdom.

Clinical Immunology and Immunopathology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The measurement of immune complexes Is it clinically useful?

Immunology today·2014
Same author

A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector.

Human gene therapy·2000
Same author

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

Human gene therapy·1999
Same author

Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector.

Human gene therapy·1998
Same author

Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.

Clinical and experimental immunology·1998
Same author

Adeno-associated virus gene transfer to mouse retina.

Human gene therapy·1998

Allogeneic bone marrow transplantation (BMT) is a successful treatment for leukemia and inherited diseases. Advances in T cell removal have reduced graft-versus-host disease (GVHD), improving outcomes for BMT patients.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Allogeneic bone marrow transplantation (BMT) is increasingly used for various diseases, including leukemia, immunodeficiency, thalassemia, and inherited metabolic disorders.
  • Historically, graft-versus-host disease (GVHD) was a major complication, limiting HLA-mismatched transplants.
  • T cell depletion techniques have significantly reduced GVHD incidence, enabling successful HLA-haploidentical transplants for immunodeficiency.

Purpose of the Study:

  • To review the evolution and current status of allogeneic bone marrow transplantation (BMT).
  • To discuss challenges in BMT, including graft rejection and leukemia relapse.
  • To explore future strategies for improving BMT efficacy and safety.

Main Methods:

  • Review of existing literature on allogeneic bone marrow transplantation (BMT).

Related Experiment Videos

  • Analysis of advancements in T cell removal techniques.
  • Discussion of novel conditioning regimens and stem cell selection methods.

    • Main Results:

    • T cell removal has diminished GVHD and enabled HLA-haploidentical transplants for immunodeficiency.
    • Graft rejection and leukemia relapse remain challenges, particularly with T cell-depleted grafts.
    • New conditioning regimens and stem cell selection strategies are under investigation to improve engraftment and reduce relapse.

    Conclusions:

    • BMT is a vital treatment for numerous diseases, with ongoing research focused on overcoming current limitations.
    • Future BMT strategies may involve positive stem cell selection and growth factors for engraftment without GVHD.
    • Autologous transplantation for malignancy may benefit from CD34+ stem cell selection, as demonstrated in primate studies.